LivaNova PLC (LIVN)

56.17 +0.64 (+1.15%) 收市：04:00PM EDT

LivaNova PLC

20 Eastbourne Terrace
London W2 6LG
United Kingdom
44 20 3325 0660
https://www.livanova.com

版塊: Healthcare
行業: Medical Devices
全職員工: 2,900

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Alex Shvartsburg	Chief Financial Officer	852.2k	無	1971
Ms. Trui Hebbelinck	Chief Human Resources Officer	731.41k	無	1973
Mr. Badri Amurthur	Chief Technology Officer	無	無	無
Lindsey Little	Senior Director of Investor Relations	無	無	無
Mr. Michael D. Hutchinson	Senior VP, Chief Legal Officer & Company Secretary	無	無	1971
Deanna Wilke	Vice President of Corporate Communications	無	無	無
Mr. Matthew Joseph Dodds III	Senior Vice President of Corporate Development & IT	無	無	無
Dr. Bryan D. Olin Ph.D.	Senior VP & Head of Product Development - Neuromodulation	無	無	1967
Mr. Ryan Miller	President of Advanced Circulatory Support	無	無	無
Ms. Stephanie Bolton	President of Global Epilepsy	無	無	1982

截止 2022年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

公司管治

截至 2024年4月1日 止，LivaNova PLC 的 ISS 管治質素評分為 2。 Pillar 分數正在審核中：5；董事會：1；股東權利：3；現金賠償：4。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。